Pyrvinium: A Novel Antifungal Agent With Unique ROS-Dependent Autophagy Induction in Candida albicans
ISEF · 2026 Cellular and Molecular Biology
Overview
Azole antifungals have served as frontline therapies for Candida infections. However, increasing azole-resistant Candida species presents a real clinical challenge requiring alternative antifungal strategies. Pyrvinium pamoate, an FDA-approved anthelmintic drug, has shown potent antifungal activity in Candida albicans by inducing an acute autophagy response independent of metabolic starvation. However, the intracellular mechanisms underlying its antifungal effect remain poorly understood.This study focuses on elucidating the pathways that mediate pyrvinium-induced fungal cell death with emphasis on the role of autophagy. Autophagy is a conserved eukaryotic stress-response pathway essential for cellular homeostasis and survival. One possible mechanism of acute autophagic induction is mediated through reactive oxygen species, ROS. I hypothesized that pyrvinium triggers ROS-dependent autophagy which reduces viability of C. albicans. To test this, I analyzed autophagy induction and quantitation, ROS production, mitochondrial activity, synergistic effect with rapamycin and cell viability with pyrvinium combined with blue light using various biochemical and cellular assays. Pyrvinium treatment rapidly increased autophagic activity and intracellular ROS levels by approximately 88% within 15 min. Mitochondrial levels were constantly elevated regardless of pyrvinium treatment. While pyrvinium combined with rapamycin showed no synergistic growth inhibition, pyrvinium combined with blue light significantly reduced C. albicans viability, demonstrating a synergistic anti-fungal effect consistent with ROS-mediated autophagy. These results support my hypothesis in which pyrvinium pamoate induces acute excessive ROS-mediated autophagy in C. albicans and subsequent cell death.
Awards (1)
- Fourth Award of $600 $600
Competition history
- ISEF 2026
Resources
Related projects
ISEF · 2026
Cyantific Sight: A Novel, Synergistic Approach to Combating Antifungal Resistance Using Naturally Derived Compounds Phycocyanobilin and Curcumin
ISEF · 2016
A Novel Treatment for Candida glabrata Infection
ISEF · 2018
Using Bioactive Compounds to Develop an Alternative to Control Candida spp.
ISEF · 2026
Harnessing Inhibition of Efflux to Reverse Antifungal Resistance
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair